Author Question: A researcher obtains t = 2.25 for a repeated-measures study using a sample of n = 10 participants. ... (Read 21 times)

jake

  • Hero Member
  • *****
  • Posts: 538
A researcher obtains t = 2.25 for a repeated-measures study using a sample of n = 10 participants. Based on this t value, what is the correct decision for a two-tailed test?
 
  a. Reject the null hypothesis with  = .05 but not with  = .01
  b. Reject the null hypothesis with both = .05 and = .01
  c. Fail to reject the null hypothesis with both = .05 and = .01
  d. Cannot make a decision without additional information

Question 2

A researcher conducts a repeated-measures study to evaluate a treatment with a sample of n = 16 participants and obtains a t statistic of t = 1.94 . The treatment is expected to increase scores and the sample mean shows an increase. Which of the following is the correct decision for a hypothesis test using  = .05?
 
  a. Reject the null hypothesis with a one-tailed test but fail to reject with two tails
  b. Reject the null hypothesis with either a one-tailed or a two-tailed test
  c. Fail to reject the null hypothesis with either a one-tailed or a two-tailed test
  d. Fail to reject the null hypothesis with a one-tailed test but reject with two tails



mk6555

  • Sr. Member
  • ****
  • Posts: 310
Answer to Question 1

C

Answer to Question 2

A



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Approximately 15–25% of recognized pregnancies end in miscarriage. However, many miscarriages often occur before a woman even knows she is pregnant.

Did you know?

Congestive heart failure is a serious disorder that carries a reduced life expectancy. Heart failure is usually a chronic illness, and it may worsen with infection or other physical stressors.

Did you know?

In ancient Rome, many of the richer people in the population had lead-induced gout. The reason for this is unclear. Lead poisoning has also been linked to madness.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

Asthma attacks and symptoms usually get started by specific triggers (such as viruses, allergies, gases, and air particles). You should talk to your doctor about these triggers and find ways to avoid or get rid of them.

For a complete list of videos, visit our video library